211 related articles for article (PubMed ID: 32577432)
1. Liver-Targeted AAV8 Gene Therapy Ameliorates Skeletal and Cardiovascular Pathology in a Mucopolysaccharidosis IVA Murine Model.
Sawamoto K; Karumuthil-Melethil S; Khan S; Stapleton M; Bruder JT; Danos O; Tomatsu S
Mol Ther Methods Clin Dev; 2020 Sep; 18():50-61. PubMed ID: 32577432
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M
PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938
[TBL] [Abstract][Full Text] [Related]
3. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
Sawamoto K; Tomatsu S
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450640
[TBL] [Abstract][Full Text] [Related]
4. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.
Rintz E; Herreño-Pachón AM; Celik B; Nidhi F; Khan S; Benincore-Flórez E; Tomatsu S
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373036
[TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?
Tomatsu S; Montaño AM; Oikawa H; Dung VC; Hashimoto A; Oguma T; Gutiérrez ML; Takahashi T; Shimada T; Orii T; Sly WS
Mol Genet Metab; 2015 Feb; 114(2):195-202. PubMed ID: 24953405
[TBL] [Abstract][Full Text] [Related]
6. Molecular therapy and nucleic acid adeno-associated virus-based gene therapy delivering combinations of two growth-associated genes to MPS IVA mice.
Rintz E; Celik B; Fnu N; Herreño-Pachón AM; Khan S; Benincore-Flórez E; Tomatsu S
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102211. PubMed ID: 38831899
[TBL] [Abstract][Full Text] [Related]
7. Sex Difference Leads to Differential Gene Expression Patterns and Therapeutic Efficacy in Mucopolysaccharidosis IVA Murine Model Receiving AAV8 Gene Therapy.
Piechnik M; Amendum PC; Sawamoto K; Stapleton M; Khan S; Fnu N; Álvarez V; Pachon AMH; Danos O; Bruder JT; Karumuthil-Melethil S; Tomatsu S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293546
[TBL] [Abstract][Full Text] [Related]
8. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.
Dũng VC; Tomatsu S; Montaño AM; Gottesman G; Bober MB; Mackenzie W; Maeda M; Mitchell GA; Suzuki Y; Orii T
Mol Genet Metab; 2013; 110(1-2):129-38. PubMed ID: 23876334
[TBL] [Abstract][Full Text] [Related]
9. Enzyme replacement therapy in a murine model of Morquio A syndrome.
Tomatsu S; Montaño AM; Ohashi A; Gutierrez MA; Oikawa H; Oguma T; Dung VC; Nishioka T; Orii T; Sly WS
Hum Mol Genet; 2008 Mar; 17(6):815-24. PubMed ID: 18056156
[TBL] [Abstract][Full Text] [Related]
10. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
Tomatsu S; Sawamoto K; Alméciga-Díaz CJ; Shimada T; Bober MB; Chinen Y; Yabe H; Montaño AM; Giugliani R; Kubaski F; Yasuda E; Rodríguez-López A; Espejo-Mojica AJ; Sánchez OF; Mason RW; Barrera LA; Mackenzie WG; Orii T
Drug Des Devel Ther; 2015; 9():1937-53. PubMed ID: 25897204
[TBL] [Abstract][Full Text] [Related]
11. Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase.
Tomatsu S; Gutierrez M; Nishioka T; Yamada M; Yamada M; Tosaka Y; Grubb JH; Montaño AM; Vieira MB; Trandafirescu GG; Peña OM; Yamaguchi S; Orii KO; Orii T; Noguchi A; Laybauer L
Hum Mol Genet; 2005 Nov; 14(22):3321-35. PubMed ID: 16219627
[TBL] [Abstract][Full Text] [Related]
12. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1.
Alméciga-Díaz CJ; Montaño AM; Tomatsu S; Barrera LA
FEBS J; 2010 Sep; 277(17):3608-19. PubMed ID: 20716181
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
[TBL] [Abstract][Full Text] [Related]
15. Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy.
Bertolin J; Sánchez V; Ribera A; Jaén ML; Garcia M; Pujol A; Sánchez X; Muñoz S; Marcó S; Pérez J; Elias G; León X; Roca C; Jimenez V; Otaegui P; Mulero F; Navarro M; Ruberte J; Bosch F
Nat Commun; 2021 Sep; 12(1):5343. PubMed ID: 34504088
[TBL] [Abstract][Full Text] [Related]
16. Iron oxide-coupled CRISPR-nCas9-based genome editing assessment in mucopolysaccharidosis IVA mice.
Leal AF; Celik B; Fnu N; Khan S; Tomatsu S; Alméciga-Díaz CJ
Mol Ther Methods Clin Dev; 2023 Dec; 31():101153. PubMed ID: 38107675
[TBL] [Abstract][Full Text] [Related]
17. A novel splicing variant in GALNS in mucopolysaccharidosis IVA and the necessity of re-evaluating primer sequences.
Kim SM; Noh ES; Park JH; Park HD; Lee SY; Jang JH; Cho SY
Ann Hum Genet; 2022 Nov; 86(6):361-368. PubMed ID: 36000290
[TBL] [Abstract][Full Text] [Related]
18. Therapies of mucopolysaccharidosis IVA (Morquio A syndrome).
Tomatsu S; Alméciga-Díaz CJ; Barbosa H; Montaño AM; Barrera LA; Shimada T; Yasuda E; Mackenzie WG; Mason RW; Suzuki Y; Orii KE; Orii T
Expert Opin Orphan Drugs; 2013 Oct; 1(10):805-818. PubMed ID: 25419501
[TBL] [Abstract][Full Text] [Related]
19. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease.
Tomatsu S; Orii KO; Vogler C; Nakayama J; Levy B; Grubb JH; Gutierrez MA; Shim S; Yamaguchi S; Nishioka T; Montano AM; Noguchi A; Orii T; Kondo N; Sly WS
Hum Mol Genet; 2003 Dec; 12(24):3349-58. PubMed ID: 14583446
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
